Cornerstone Investment Partners LLC Has $72.79 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Cornerstone Investment Partners LLC decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 12.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 210,659 shares of the company's stock after selling 30,504 shares during the period. HCA Healthcare comprises 3.5% of Cornerstone Investment Partners LLC's portfolio, making the stock its 9th largest holding. Cornerstone Investment Partners LLC owned about 0.09% of HCA Healthcare worth $72,793,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Congress Wealth Management LLC DE grew its stake in shares of HCA Healthcare by 3.4% in the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after buying an additional 34 shares in the last quarter. Perigon Wealth Management LLC grew its holdings in HCA Healthcare by 2.3% during the first quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company's stock valued at $621,000 after purchasing an additional 40 shares during the last quarter. Whittier Trust Co. lifted its stake in shares of HCA Healthcare by 3.6% in the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock worth $359,000 after buying an additional 41 shares during the last quarter. Barden Capital Management Inc. grew its stake in HCA Healthcare by 1.4% in the 1st quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock valued at $1,009,000 after buying an additional 41 shares during the last quarter. Finally, Coldstream Capital Management Inc. lifted its position in HCA Healthcare by 1.3% during the 4th quarter. Coldstream Capital Management Inc. now owns 3,471 shares of the company's stock worth $1,042,000 after acquiring an additional 44 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on HCA. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Royal Bank Of Canada restated an "outperform" rating and issued a $404.00 price target (up from $376.00) on shares of HCA Healthcare in a research report on Monday, June 23rd. Barclays set a $416.00 target price on shares of HCA Healthcare and gave the company an "overweight" rating in a research note on Monday, June 2nd. Morgan Stanley set a $410.00 price target on HCA Healthcare and gave the company an "equal weight" rating in a report on Monday, June 9th. Finally, Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Seven investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of "Moderate Buy" and an average target price of $395.71.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the transaction, the chief operating officer directly owned 12,646 shares in the company, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Price Performance

HCA stock traded down $2.56 during trading on Friday, hitting $375.76. 877,097 shares of the stock traded hands, compared to its average volume of 1,459,427. The stock has a market cap of $90.40 billion, a price-to-earnings ratio of 16.71, a P/E/G ratio of 1.31 and a beta of 1.47. The company has a 50 day simple moving average of $375.13 and a 200 day simple moving average of $341.72. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The firm had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. During the same quarter in the previous year, the company posted $5.36 EPS. The business's revenue for the quarter was up 5.7% compared to the same quarter last year. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were given a dividend of $0.72 per share. The ex-dividend date was Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.77%. HCA Healthcare's payout ratio is 12.81%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.